scRNAseq of CD4+ T cells from several breast cancer subtypes reported that CD4+ TEM and TCM clusters exhibit variable levels of gene expression involved in type I and II interferon response, hypoxia, and anergy, indeed indicating a different signaling and role in the tumor [21]. Here, CD4 is linked to breast carcinoma.